Methionine depletion enhances the antitumoral efficacy of cytotoxic agents in drug-resistant human tumor xenografts

Clinical Cancer Research

Volumn 6, Issue 2, 2000, Pages 643-653

  Poirson Bichat, F ^a   Goņalves, R A Bras ^a   Miccoli, L ^a   Dutrillaux, B ^a   Poupon, M F ^a  

^a CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTIINFECTIVE AGENT; CARMUSTINE; CISPLATIN; CYTOTOXIC AGENT; DOXORUBICIN; ETHIONINE; GLUTATHIONE PEROXIDASE; HOMOCYSTEINE; METHIONINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER; CANCER CHEMOTHERAPY; CANCER GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR XENOGRAFT;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANTINEOPLASTIC AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; BRAIN NEOPLASMS; CARCINOMA, SMALL CELL; CELL DIVISION; COLONIC NEOPLASMS; DIETARY SUPPLEMENTS; DRUG RESISTANCE, MULTIPLE; ETHIONINE; FEMALE; GENES, MDR; GLIOMA; GLUTATHIONE; HOMOCYSTEINE; HUMANS; LUNG NEOPLASMS; MALE; METHIONINE; MICE; MICE, NUDE; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NEOPLASMS; TRANSCRIPTION, GENETIC; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0342980325     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Warburg, O. On the origin of cancer cells. Science (Washington DC), 123: 309-314, 1956.
2. Hoffman, R. M. Altered methionine metabolism, DNA methylation and oncogene expression in carcinogenesis. Biochem. Biophys. Acta, 738: 49-87, 1984.
3. Hoffman, R. M. Altered methionine metabolism and transmethylation in cancer. Anticancer Res., 5: 1-30, 1985.
4. Breillout, F., Poupon, M. F., Blanchard, P., Lascaux, V., Echinard-Garin, P., and Robert-Gero, M. Association of SIBA treatment and a Met-depleted diet inhibits in vitro growth and in vivo metastatic spread of experimental tumor cell lines. Clin. Exp. Metastasis, 6: 3-16, 1988.
5. Breillout, F., Antoine, E., Lascaux, V., Rolland, Y., and Poupon, M. F. Promotion of micrometastasis proliferation in a rat rhabdomyosarcoma model by epidermal growth factor. J. Natl. Cancer Inst., 81: 702-705, 1989.
6. Breillout, F., Antoine, E., and Poupon, M. F. Methionine dependency of malignant tumors: a possible approach for therapy. J. Natl. Cancer Inst., 82: 1628-1632, 1990.
7. Guo, H. Y., Herrera, H., Groce, A., and Hoffman, R. M. Expression of the biochemical defect of methionine dependence in fresh patient tumors in primary histoculture. Cancer Res., 53: 2479-2483, 1993.
8. Guo, H., Lishko, V. K., Herrera, H., Groce, A., Kubota, T., and Hoffman, R. M. Therapeutic tumor-specific cell cycle block induced by methionine starvation in vivo. Cancer Res., 53: 5676-5679, 1993.
9. Guo, H., Tan, Y., Kubota, T., Moossa, A. R., and Hoffman, R. M. Methionine depletion modulates the antitumor and antimetastatic efficacy of ethionine. Anticancer Res., 16: 2719-2723, 1996.
10. Poirson-Bichat, F., Lopez, R., Bras Goncalves, R. A., Miccoli, L., Bourgeois, Y., Demerseman, P., Poisson, M., Dutrillaux, B., and Poupon, M. F. Methionine deprivation and methionine analogs inhibit cell proliferation and growth of human xenografted gliomas. Life Sci., 60: 919-931, 1997.
11. Poirson-Bichat, F., Gonfalone, G., Bras-Goncalves, R. A., Dutrillaux, B., and Poupon, M. F. Growth of methionine-dependent human prostate cancer (PC-3) is inhibited by ethionine combined with methionine starvation. Br. J. Cancer, 75: 1605-1612, 1997.
12. Tan, Y., Xu, M., Guo, H., Sun, X., Kubota, T., and Hoffman, R. M. Anticancer efficacy of methioninase in vivo. Anticancer Res., 16: 3931-3936, 1996.
13. Tan, Y., Zavala, J., Sr., Han, Q., Xu, M., Sun, X., Tan, X., Tan, X., Magana, R., Geller, J., and Hoffman, R. M. Recombinant methioninase infusion reduces the biochemical endpoint of serum methionine with minimal toxicity in high-stage cancer patients. Anticancer Res., 17: 3857-3860, 1997.
14. Goseki, N., Yamasaki, S., Endo, M., Onodera, T., Kosaki, G., Hibino, Y., and Kuwahata, T. Antitumor effect of methionine-depleting total parenteral nutrition with doxorubicin administration on Yoshida-sarcoma-bearing rats. Cancer (Phila.), 69: 1865-1872, 1992.
15. Nagahama, T., Goseki, N., and Endo, M. Doxorubicin and vincristine with methionine depletion contributed to survival in the Yoshida sarcoma bearing rats. Anticancer Res., 18: 25-31, 1998.
16. Breillout, F., Hadida, F., Echinard-Garin, P., Lascaux, V., and Poupon, M. F. Decreased rat rhabdomyosarcoma pulmonary metastases in response to a low methionine diet. Anticancer Res., 7: 861-867, 1987.
17. Razin, A., and Riggs, A. D. DNA methylation and gene function. Science (Washington DC), 210: 604-610, 1980.
18. Tan, Y., Xu, M., Guo, H., Sun, X., Kubota, T., and Hoffman, R. M. Anticancer efficacy of methioninase in vivo. Anticancer Res., 16: 3931-3936, 1996.
19. Abraham, E. H., Prat, A. G., Gerweck, L., Seneveratne, T., Arceci, R. J., Kramer, R., Guidotti, G., and Cantiello, H. F. The multidrug resistance (mdr1) gene product functions as an ATP channel. Proc. Natl. Acad. Sci. USA, 90: 312-316, 1993.
20. Broxterman, H. J., and Pinedo, H. M. Energy metabolism in multidrug resistant tumor cells: a review. J. Cell. Pharmacol., 2: 239-247, 1991.
21. Flens, M. J., Scheffer, G. L., van der Valk, P., Broxterman, H. J., Eijdems, E. W., Huysmans, A. C., Izquierdo, M. A., and Scheper, R. J. Identification of novel drug resistance-associated proteins by a panel of rat monoclonal antibodies. Int. J. Cancer. 73: 249-257, 1997.
22. Cole, S. P., and Deeley, R. G. Multidrug resistance mediated by the ATP-binding cassette transporter protein MRP. Bioessays, 20: 931-940, 1998.
23. Tew, K. D. Glutathione-associated enzymes in anticancer drug resistance. Cancer Res., 54: 4313-4320, 1994.
24. Shen, H., Kauvar, L., and Tew, K. D. Importance of glutathione and associated enzymes in drug response. Oncol. Res., 9: 295-302, 1997.
25. Goseki, N., Nagahama, T., Maruyama, M., and Endo, M. Enhanced anticancer effect of vincristine with methionine infusion after methionine-depleting total parenteral nutrition in tumor-bearing rats. Jpn. J. Cancer Res., 87: 194-199, 1996.
26. Nagahama, T., Goseki, N., and Endo, M. Doxorubicin and vincristine with methionine depletion contributed to survival in the Yoshida sarcoma bearing rats. Anticancer Res., 18: 25-31, 1998.
27. Goseki, N., Yamazaki, S., Shimojyu, K., Kando, F., Maruyama, M., Endo, M., Koike, M., and Takahashi, H. Synergistic effect of methionine-depleting total parenteral nutrition with 5-fluorouracil on human gastric cancer: a randomized, prospective clinical trial. Jpn. J. Cancer Res., 86: 484-489, 1995.
28. Bichat, F., Mouawad, R., Solis-Recendez, G., Khayat, D., and Bastian, G. Cytoskeleton alteration in MCF7R cells, a multidrug resistant human breast cancer cell line. Anticancer Res., 17: 3393-3401, 1997.
29. Chevillard, S., Pouillart, P., Beldjord, C., Asselain, B., Beuzeboc, P., Magdelenat, H., and Vielh, P. Sequential assessment of multidrug resistance phenotype and measurement of S-phase fraction as predictive markers of breast cancer response to neoadjuvant chemotherapy. Cancer (Phila.), 77: 292-300, 1996.
30. Gross, J. L., Behrens, D. L., Mullins, D. E., Kornblith, P. L., and Dexter, D. L. Plasminogen activator and inhibitor activity in human glioma cells and modulation by sodium butyrate. Cancer Res., 48: 291-296, 1988.
31. Lefrançois, D., Olschwang, S., Delattre, O., Muleris, M., Dutrillaux, A. M., Thomas, G., and Dutrillaux, B. Preservation of chromosome and DNA characteristics of human colorectal adenocarcinomas after passage in nude mice. Int. J. Cancer, 44: 871-878, 1989.
32. Arvelo, F., Poupon, M. F., Goguel, A. F., Lizard, G., Bourgeois, Y., Arriagada, R., and Le Chevalier, T. Response of a multidrug-resistant human small-cell lung cancer xenograft to chemotherapy. J. Cancer Res. Clin. Oncol., 120: 17-23, 1993.
33. Poupon, M. F., Arvelo, F., Goguel, A. F., Bourgeois, Y., Jacrot, M., Hanania, N., Arriagada, R., and Le Chevalier, T. Response of small-cell lung cancer xenografts to chemotherapy: multidrug resistance and direct clinical correlates. J. Natl. Cancer Inst., 85: 2023-2029, 1993.
34. Houghton, P. J., Cheshire, P. J., Hallman, J. D., II, Lutz, L., Friedman, H. S., Danks, M. K., and Houghton, J. A. Efficacy of topoisomerase I inhibitors, topotecan and irinotecan, administered at low dose levels in protracted schedules to mice bearing xenografts of human tumors. Cancer Chemother. Pharmacol. 36: 393-403, 1995.
35. Tisdale, M. J. Utilization of performed and endogenously synthesized methionine by cells in tissue culture. Br. J. Cancer, 49: 315-320, 1984.
36. Hoshiya, Y., Guo, H., Kubota, T., Inada, T., Asanuma, F., Yamada, Y., Koh, J., Kitajima, M., and Hoffman, R. Human tumors are methionine dependent in vivo. Anticancer Res., 15: 717-718, 1995.
37. Hunter, E., and Grimble, R. Dietary sulphur amino acid adequacy influences glutathione synthesis and glutathione-dependent enzymes during the inflammatory response to endoxin and tumour necrosis factor-α in rats. Clin. Sci., 92: 297-305, 1997.
38. Morand, C., Rios, L., Moundras, C., Besson, C., Remesy, C., and Demigne, C. Influence of methionine availability on glutathione synthesis and delivery by the liver. Nutr. Biochem., 8: 246-255, 1997.
39. Scott, J., and Weir, D. The methyl folate trap: a physiological response in man to prevent methyl group deficiency in kwashiorkor (methionine deficiency) and an explanation for folic-acid-induced exacerbation of subacute combined degeneration in pernicious anemia. Lancet, 2: 337-340, 1981.
40. James. S., Miller, B., McGarrity, L., and Morris, S. The effect of folic acid and/or methionine deficiency on deoxyribonucleotide pools and cell cycle distribution in mitogen-stimulated rat lymphocytes. Cell Prolif., 27: 395-406, 1994.
41. Li, J. C., and Kaminskas, E. Accumulation of DNA strand breaks and methotrexate cytotoxicity. Proc. Natl. Acad. Sci. USA, 81: 5694-5698, 1984.
42. Holliday, R. Aspects of DNA repair and nucleotide pool imbalance. Basic Life Sci., 31: 453-460, 1985.
43. Yoshioka, A., Tanaka, S., Hiraoka, O., Koyama, Y., Hirota, Y., Ayusawa, D., Seno, T., Garrett, C., and Wataya, Y. Deoxyribonucleoside triphosphate imbalance. 5-Fluorodeoxyuridine-induced DNA double strand breaks in mouse FM3A cells and the mechanism of cell death. J. Biol. Chem., 262: 8235-8241, 1987.
44. Oliver, F. J., Collins, M. K., and Lopez-Rivas, A. dNTP pools imbalance as a signal to initiate apoptosis. Experientia, 52: 995-1000, 1996.
45. Thomas, T., Faaland, C. A., Adhikarakunnathu, S., and Thomas, T. J. Structure-activity relations of S-adenosylmethionine decarboxylase inhibitors on the growth of MCF-7 breast cancer cells. Breast Cancer Res. Treat., 39: 293-306, 1996.
46. Cox, R., and Irving, C. C. Inhibition of DNA Methylation by S-adenosylethionine with the production of methyl-deficient DNA in regenerating Rat Liver. Cancer Res., 37: 222-225, 1977.
47. Christman, J., Sheikhnejad, G., Dizik, M., Abileah, S., and Wainfan, E. Reversibility of changes in nucleic acid methylation and gene expression induced in rat liver by severe dietary methyl deficiency. Carcinogenesis (Lond.), 551-557, 1993.
48. Canitrot, Y., Bichat, F., Cole, S. P., Deeley, R. G., Gerlach, J. H., Bastian, G., Arvelo, F., and Poupon, M. F. Multidrug resistance genes (MRP) and MDR1 expression in small cell lung cancer xenografts: relationship with response to chemotherapy. Cancer Lett., 130: 133-141, 1998.
49. Arvelo, F., Poupon, M. F., Bichat, F., Grossin, F., Bourgeois, Y., Jacrot, M., Bastian, G., and Le Chevalier, T. Adding a reverser (verapamil) to combined chemotherapy overrides resistance in small cell lung cancer xenografts. Eur. J. Cancer, 31A: 1862-1868, 1995.
50. Pujol, J. L., Douillard, J. Y., Riviere, A., Quoix, E., Lagrange, J. L., Berthaud, P., Bardonnet-Comte, M., Polin, V., Gautier, V., Milleron, B., Chomy, F., Chomy, P., Spaeth, D., and Le Chevalier, T. Dose-intensity of a four-drug chemotherapy regimen with or without recombinant human granulocyte-macrophage colony-stimulating factor in extensive-stage small-cell lung cancer: a multicenter randomized Phase III study. J. Clin. Oncol., 15: 2082-2089, 1997.
51. Kisara, S., Furusawa, S., Takayanagi, Y., and Sasaki, K. Effect of glutathione depletion by buthionine sulfoximine on doxorubicin toxicity in mice. Res. Com. Mol. Pathol. Pharmacol., 89: 401-410, 1995.
52. Scheithauer, W., Depisch, D., Kornek, G., Pidlich, J., Rosen, H., Karall, M., Prochaska, M., Ernst, A., Sebesta, C., and Eckhardt, S. Randomized comparison of fluorouracil and leucovorin therapy versus fluorouracil, leucovorin, and cisplatin therapy in patients with advanced colorectal cancer. Cancer (Phila.), 73: 1562-1568, 1994.
53. Sagaster, P., Essl, R., Teich, G., Fritz, E., Wasilewski, M., Umek, H., Dunser, E., Mascher, H., and Micksche, M. Treatment of advanced colorectal cancer with folinic acid and 5-fluorouracil in combination with cisplatinum. Eur. J. Cancer, 30A: 1250-1254, 1994.
54. Mineura, K., Sasajima, T., Sasajima, H., and Kowada, M. Inhibition of methionine uptake by cis-diamminedichloroplatinum (II) in experimental brain tumors. Int. J. Cancer, 67: 681-683, 1996.
55. Chen, Z., Muto, M., Sumizawa, T., Furukawa, T., Haraguchi, M., Tani, A., Saijo, N., Kondo, T., and Akiyama, S. An active efflux system for heavy metals in cisplatin-resistant human KB carcinoma cells. Exp. Cell Res., 240: 312-320, 1998.
56. Brandes, A. A., Scelzi, E., Zampieri, P., Rigon, A., Rotilio, A., Amista, P., Berti, F., and Fiorentino, M. V. Phase II trial with BCNU plus α-interferon in patients with recurrent high-grade gliomas. Am. J. Clin. Oncol., 20: 364-367, 1997.
57. Gundersen, S., Lote, K., and Watne, K. A retrospective study of the value of chemotherapy as adjuvant therapy to surgery and radiotherapy in grade 3 and 4 gliomas. Eur. J. Cancer, 34: 1565-1569, 1998.
58. Allalunis-Turner, M., Day, R., McKean, J., Petruk, K., Allen, P., Aronyk, K., Weir, B., Huyser-Wierenga, D., Fulton, D., and Urtasun, R. Glutathione levels and chemosensitizing effects of buthionine sulfoximine in human malignant glioma cells. J. Neurooncol., 11: 157-164, 1991.